Salvage allogeneic hematopoietic SCT for primary graft failure in children

[1]  Tao Wang,et al.  Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. , 2012, Blood.

[2]  K. Kawa,et al.  Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  H. Tamaki,et al.  Salvage haploidentical transplantation for graft failure using reduced-intensity conditioning , 2012, Bone Marrow Transplantation.

[4]  K. Sullivan,et al.  Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation , 2011, Bone Marrow Transplantation.

[5]  M. Taniwaki,et al.  Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  S. Nakao,et al.  Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation , 2010, International journal of hematology.

[7]  M. Pasquini,et al.  Second unrelated donor hematopoietic cell transplantation for primary graft failure. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  Zimin Sun,et al.  Successful second transplantation with non‐myeloablative conditioning using haploidentical donors for young patients after graft failure following double umbilical cord cell transplantation , 2010, Pediatric transplantation.

[9]  J. Klein,et al.  The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. , 2007, Blood.

[10]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  M. Sorror,et al.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  C. Dvorak,et al.  Primary graft failure after umbilical cord blood transplant rescued by parental haplocompatible stem cell transplantation. , 2009, Journal of pediatric hematology/oncology.

[13]  C. Belka,et al.  Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. , 2006, Blood cells, molecules & diseases.

[14]  K. Kawa,et al.  Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System , 2007, International journal of hematology.

[15]  E. Jabbour,et al.  Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation , 2007, Bone Marrow Transplantation.

[16]  F. Baron,et al.  Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning , 2006, Leukemia.

[17]  R. Collins,et al.  Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. , 2006, Blood.

[18]  A. Larocca,et al.  Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. , 2006, Haematologica.

[19]  G. Mufti,et al.  The impact of donor factors on primary non-engraftment in recipients of reduced intensity conditioned transplants from unrelated donors. , 2005, Haematologica.

[20]  S. Wolff.  Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation , 2002, Bone Marrow Transplantation.

[21]  R. Collins,et al.  Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  Dong-Wook Kim,et al.  Additional Stem Cell Therapy for Graft Failure after Allogeneic Bone Marrow Transplantation , 2001, Acta Haematologica.

[23]  D. Blaise,et al.  Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia , 2000, British journal of haematology.

[24]  G. Lucarelli,et al.  Second marrow transplants for graft failure in patients with thalassemia , 1999, Bone Marrow Transplantation.

[25]  P. Ljungman,et al.  Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation , 1998, Bone Marrow Transplantation.

[26]  C Anasetti,et al.  Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.

[27]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. , 1994, Blood.

[28]  P. Ljungman,et al.  Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. , 1994, Bone marrow transplantation.

[29]  K. Sullivan,et al.  Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. , 1989, The New England journal of medicine.